Burak Giray

Dr. Burak Giray

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
GBGulchin Babayeva
Gulchin Babayeva
YPYunus Emre Purut
Yunus Emre Purut
BGBurak Giray
Burak Giray
DODoç.Dr. Pembe OLTULU
Doç.Dr. Pembe OLTULU
RARabia Alakuş
Rabia Alakuş
MÇMehmet Cengiz Çolakoğlu
Mehmet Cengiz Çolakoğlu
Implantation failure is a multifactorial problem of reproductive medicine. However, the mechanism of this process is still not fully understood. There is increasing evidence that these cases of recurrent implantation failure might have an immunologic background. Uterine natural killer (NK) cells provide immune-modulation at the interface between maternal decidua and the trophoblast. The aim of this study to evaluate whether there was a significant difference in the number of endometrial CD56+ NK between women with a history of recurrent implantation failure and women who had a live birth. Patients with a history of recurrent implantation failure were included in the study. Twenty-five women with a history of recurrent implantation failure were assigned to the case group, and 25 women who had one or more live births were assigned to the control group. Endometrial biopsies were obtained during the luteal phase on the 21st-24th day of the menstrual cycle. There was a statistically significant difference between the groups concerning the number of deliveries (p<0.001) and miscarriages (p<0.001). The mean number of uNK was 10.5±10.5 cells/mm2 in the case group and 19.2±11.2 cells/mm2 in the control group. There was a statistically significant difference between the two groups (p=0.003). Implantation failure is a multifactorial problem of reproductive medicine. The results of our study suggest that uterine NK play a role in the progress of normal pregnancy and reduced uterine NK cell numbers were associated with implantation failure.

2 February 2021 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
PDF file
CKCanan Kabaca
Canan Kabaca
BGBurak Giray
Burak Giray
MUMine Guray Uzun
Mine Guray Uzun
SASerkan Akis
Serkan Akis
YPYunus Emre Purut
Yunus Emre Purut
EEEvrim Bostanci Ergen
Evrim Bostanci Ergen

28 December 2020 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
ÖSÖnder Sakin
Önder Sakin
SUSakine Betül Uzun
Sakine Betül Uzun
KKKazibe Koyuncu
Kazibe Koyuncu
BGBurak Giray
Burak Giray
EAEmine Eda Akalın
Emine Eda Akalın
AAAli Doğukan Anğın
Ali Doğukan Anğın
Objective: To investigate whether testing positive for human papilloma virus (HPV) in cervical screening has an impact on female sexual functioning. Materials and Methods: This study was designed as a single-center, prospective, descriptive-cross-sectional study and 300 women who received HPV testing in our hospital [HPV-positive (n=187) or HPV-negative (n=113)]. The Arizona Sexual Experiences (ASEX) scale and Female Sexual Functioning index (FSFI) were administered to study participants during face-to-face interviews. Results: No significant differences were found between women who were HPV positive and HPV negative in sexual functions as assessed using the ASEX and FSFI scales (p=0.343 and p=0.604, respectively). In addition, the analyses addressing whether sexual functioning was affected by a positive test result, at diagnosis or during the follow-up (before 2 weeks, 2 weeks-1 month, 1-3 months, 3-6 months, 6 months-1 year and over 1 year) revealed no significant differences between HPV -positive and HPV negative women in sexual functioning (p>0.05). Sexual dysfunction was less common in married women than in the ASEX scale (p=0.03), and this difference was not detected when the FSFI scale was applied. The incidence of dysfunction was more frequent in working women than in retirees (p=0.006, p=0.01). Conclusion: Educational attainment, socioeconomic status, age, employment status, and marital status were found to have statistically significant effects on sexual functioning. Sexual functioning was affected by neither HPV test results (positive/negative) nor time from diagnosis.

26 April 2018 in Geburtshilfe und Frauenheilkunde
Verified
Journal Article
Open access
PDF file
BGBurak Giray
Burak Giray
EEEsra Esim-Buyukbayrak
Esra Esim-Buyukbayrak
SHSevinc Hallac-Keser
Sevinc Hallac-Keser
AKAyse Yasemin Karageyim-Karsidag
Ayse Yasemin Karageyim-Karsidag
ATAysegul Turkgeldi
Aysegul Turkgeldi
Introduction We aimed to compare the presence and the amount of nerve fibers in endometrial, myometrial and leiomyoma tissues using protein gene product 9.5 (PGP 9.5) and neurofilament (NF) immunohistochemical staining in uterine leiomyoma patients with and without pain complaint. Methods Patients undergoing hysterectomy for uterine leiomyoma were prospectively enrolled in the study. Twenty-five uterine leiomyoma patients without pelvic pain complaint (visual analog scale (VAS) < 5) were assigned to Group 1; 23 uterine leiomyoma patients with pelvic pain complaint (VAS ≥ 5) were assigned to Group 2. Endometrial, myometrial and leiomyoma tissues obtained from hysterectomy specimens were stained immunohistochemically using PGP 9.5 and NF dyes. The presence and density of nerve fibers were compared between the two groups. Results None of the endometrial samples in either groups stained with PGP 9.5 and NF dyes. There was no statistically significant difference in the number of nerve fibers in myometrial and leiomyoma tissues between the two groups with either of the stains (PGP 9.5: p = 0.39 and p = 0.29; NF: p = 0.83 and p = 0.65, respectively). There was agreement between PGP 9.5 and NF immunohistochemical staining for nerve fiber detection in myometrial and leiomyoma tissues (p < 0.05/κ = 0.622 and p < 0.05/κ = 0.388, respectively). Conclusion This study demonstrates that the quantity and density of nerve fibers in myometrial and leiomyoma tissue in patients with pain were similar to that in patients without pain.

1 May 2021 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
YPYunus Emre Purut
Yunus Emre Purut
BGBurak Giray
Burak Giray
EGEsra Gürbüz
Esra Gürbüz
The new type of coronavirus could cause severe acute respiratory syndrome and injuries in other systems as well. Multiple organ damage can occur rapidly in patients infected with coronavirus disease 2019 (COVID‐19). Previous studies have shown that many laboratory biomarkers were not within the normal ranges in COVID‐19 patients. We aimed to summarize laboratory parameters and the tumor markers in COVID‐19 patients. This is a retrospective cohort study conducted on 53 women between the ages of 19–85 years infected with COVID‐19 at a training and research hospital between May 2020 and August 2020. Of the 53 women, 16 (30.2%) had leukopenia. The mean C‐reactive protein level was 18.42 ± 59.33 mg/L. The mean procalcitonin level was 0.1 ± 0.21 µg/L. The liver function tests were within normal limits. The mean creatinine level was 0.58 ± 0.37 mg/dl. Elevated levels of α‐fetoprotein (AFP) in 1 patient, elevated levels of carcinoembryonic antigen (CEA) in 2 patients, elevated levels of cancer antigen 125 (CA125) in 4 patients, elevated levels of CA19‐9 in 2 patients, and elevated levels of CA15‐3 in 2 patients were detected. One of 4 patients who were taken to the intensive care unit had elevated levels of AFP. In addition, 2 of 4 patients who were taken to the intensive care unit had elevated levels of CA125 and CA15‐3. Except for AFP, levels of all tumor markers of the patient who died were high. We found that COVID‐19 had no effect on tumor markers (CA125, CA19‐9, CA15‐3, AFP, and CEA).

2 October 2020 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
BGBurak Giray
Burak Giray
CKCanan Kabaca
Canan Kabaca
MUMine Guray Uzun
Mine Guray Uzun
SASerkan Akis
Serkan Akis
YPYunus Emre Purut
Yunus Emre Purut
HCHandan Cetiner
Handan Cetiner